Filing Details

Accession Number:
0001179110-13-010855
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-25 16:42:30
Reporting Period:
2013-06-21
Filing Date:
2013-06-25
Accepted Time:
2013-06-25 16:42:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Synta Pharmaceuticals Corp SNTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325713 Bruce Kovner C/O Caxton Corporation
731 Alexander Road, Bldg 2
Princeton NJ 08540
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-24 200,000 $4.43 2,450,000 No 4 P Indirect By Kovner 2012 Family Trust B
Common Stock Acquisiton 2013-06-21 50,000 $4.23 2,250,000 No 4 P Indirect By Kovner 2012 Family Trust B
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Kovner 2012 Family Trust B
No 4 P Indirect By Kovner 2012 Family Trust B
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,170,330 Direct
Common Stock 125,000 Indirect By Kovner 2011-A Investment Trust
Common Stock 125,000 Indirect By Kovner 2011-B Investment Trust
Common Stock 125,000 Indirect By Kovner 2011-C Investment Trust
Common Stock 125,000 Indirect By Kovner 2011-D Investment Trust
Common Stock 475,000 Indirect By Kovner 2012-A Synta Investment Trust
Common Stock 475,000 Indirect By Kovner 2012-B Synta Investment Trust
Common Stock 475,000 Indirect By Kovner 2012-C Synta Investment Trust
Common Stock 475,000 Indirect By Kovner 2012-D Synta Investment Trust
Common Stock 4,199,803 Indirect By KFO Holdings LLC
Common Stock 7,761,716 Indirect By CxSynta LLC
Footnotes
  1. The shares were purchased in multiple transactions at prices ranging from $4.25 to $4.52 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.
  2. The shares were purchased in multiple transactions at prices ranging from $3.92 to $4.35 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.
  3. These shares are owned directly by KFO Holdings LLC ("KFO") and indirectly by the Reporting Person as the sole member of KFO.
  4. These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.